NBTXR3
Showing 1 - 13 of 13
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Houston (other,
Recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma
- Hafnium Oxide-containing Nanoparticles NBTXR3
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal
Recruiting
- Borderline Resectable Pancreatic Adenocarcinoma
- +3 more
- Hafnium Oxide-containing Nanoparticles NBTXR3
- Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal
Recruiting
- Cervical Esophagus Adenocarcinoma
- +12 more
- Capecitabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Liver, Metastatic Malignant Tumor in the Lung Trial in Houston
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Hafnium Oxide-containing Nanoparticles NBTXR3
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Worldwide (NBTXR3, Cetuximab, Radiation Therapy)
Recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- NBTXR3
- +2 more
-
Tampa, Florida
- +17 more
Mar 22, 2022
Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston (Hafnium
Recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- +13 more
- Hafnium Oxide-containing Nanoparticles NBTXR3
- Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2021
Prostate Cancer Trial in Boston, Philadelphia (NBTXR3 activated by IMRT only, NBTXR3 activated by Brachytherapy & IMRT)
Terminated
- Prostate Cancer
- NBTXR3 activated by IMRT only
- NBTXR3 activated by Brachytherapy & IMRT
-
Boston, Massachusetts
- +1 more
May 5, 2021
Liver Cancer Trial in France (NBTXR3, IL or IA injection + SBRT)
Terminated
- Liver Cancer
- NBTXR3, IL or IA injection + SBRT
-
Lyon, France
- +6 more
May 5, 2021
Rectal Cancer Trial in Kaohsiung City (drug, procedure, radiation)
Terminated
- Rectal Cancer
- PEP503
- +4 more
-
Kaohsiung City, TaiwanKaohsiung Medical University Hospital
Dec 17, 2021
Head and Neck Squamous Cell Carcinoma Trial in Keelung (PEP503, Cisplatin, Radiotherapy)
Terminated
- Head and Neck Squamous Cell Carcinoma
- PEP503
- +2 more
-
Keelung, TaiwanKeelung Chang Gung Memorial Hospital (Lovers Lake Branch)
Dec 17, 2021
Adult Soft Tissue Sarcoma Trial in Bordeaux, Villejuif (NBTXR3)
Completed
- Adult Soft Tissue Sarcoma
- NBTXR3
-
Bordeaux, France
- +1 more
Oct 4, 2020
Head Neck Cancer Trial in Worldwide (NBTXR3 activated by IMRT)
Recruiting
- Head and Neck Cancer
- NBTXR3 activated by IMRT
-
Caen, France
- +19 more
May 5, 2021
Adult Soft Tissue Sarcoma Trial in Worldwide (NBTXR3, Radiation therapy)
Completed
- Adult Soft Tissue Sarcoma
- NBTXR3
- Radiation therapy
-
Canberra, Australia
- +41 more
Apr 5, 2021